Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06637774 · ClinicalTrials.gov registry record · NA

The Aspirometer: A Noninvasive Tool for Detecting Aspiration Aim 3

A NA study of Deglutition Disorders, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06637774 is a NA study of Deglutition Disorders that has completed, run by University of Pittsburgh. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06637774, a NA study of Deglutition Disorders, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This investigation evaluates the effectiveness of a device called the Aspirometer, which uses high resolution cervical auscultation (HRCA), in detecting when food or liquids enter the airway (aspiration) of the person swallowing, whether the person swallowing shows signs of aspiration (coughing) or not.

Conditions Studied

Interventions

  • DEVICE Aspirometer
  • DEVICE Videofluoroscopic X-ray

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Medical Center Oakland campus - Pittsburgh

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-09-30
Est. Completion 2023-05-31
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT06637774

The ClinicalTrials.gov registry entry for NCT06637774 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Deglutition Disorders appearing as the primary indexed condition, and to 2 interventions - of which Aspirometer is the first listed.

NCT06637774 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06637774 about?

NCT06637774 is a clinical study titled "The Aspirometer: A Noninvasive Tool for Detecting Aspiration Aim 3". This investigation evaluates the effectiveness of a device called the Aspirometer, which uses high resolution cervical auscultation (HRCA), in detecting when food or liquids enter the airway (aspiration) of the person swallowing, whether the person swallowing shows signs of aspiration (coughing) or ...

What is the current status of trial NCT06637774?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-09-30. Estimated completion is 2023-05-31.

What conditions does trial NCT06637774 study?

This clinical trial studies the following conditions: Deglutition Disorders.

What interventions are being tested in trial NCT06637774?

The interventions under investigation include: Aspirometer (DEVICE), Videofluoroscopic X-ray (DEVICE).

Who is sponsoring clinical trial NCT06637774?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06637774 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Deglutition Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.